SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001735276-23-000002
Filing Date
2023-01-09
Accepted
2023-01-09 16:05:26
Documents
2
Period of Report
2023-01-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 1491
2 EDGAR SUPPORTING DOCUMENT bertozzi_20221217poa.txt EX-24 4110
  Complete submission text file 0001735276-23-000002.txt   7079
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Business Address
Bertozzi Carolyn R (Reporting) CIK: 0001698766 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36407 | Film No.: 23518126